Key Takeaways
- L-2 EAD licensed pharmacists can own and operate independent pharmacies
- Independent pharmacies earn 30-60% higher margins than chains on specialty and compounding
- SBA pharmacy loans blocked for non-citizens — Bankable fills the funding gap
- Fund pharmacy buildout, drug inventory, and POS systems without a green card
- Bankable evaluates your dispensing revenue, not your immigration status
Independent pharmacies are a natural business for L-2 EAD holders who are licensed pharmacists. Many L-2 spouses from countries like India, South Korea, and Japan arrive with pharmacy degrees and professional experience. US pharmacy licensure requires passing the NAPLEX and MPJE examinations plus state-specific requirements, but once licensed, an L-2 EAD pharmacist can own and operate an independent pharmacy.
Independent pharmacies — particularly those serving specific ethnic communities, offering specialty compounding, or focusing on long-term care — can generate strong revenue with margins significantly higher than chain pharmacies. Bankable funds L-2 EAD pharmacy businesses based on prescription volume, specialty pharmacy revenue, and ancillary service income.
Pharmacy Funding Uses
- Drug inventory: Initial formulary stock and ongoing inventory management capital
- Pharmacy fit-out: Dispensing counters, shelving, refrigeration, and pharmacy management systems
- POS and pharmacy software: Pharmacy information systems, point-of-sale, and insurance billing platforms
- Compounding equipment: Sterile and non-sterile compounding equipment for specialty pharmacy
- Working capital: Bridge between prescription dispensing costs and insurance reimbursement
- MTM services: Medication therapy management program development and marketing
Frequently Asked Questions
Yes. L-2 EAD licensed pharmacists can own and operate independent pharmacies. You must hold a valid pharmacist license in the state(s) where you operate. Pharmacy ownership regulations vary by state — some require the majority owner to be a pharmacist, which an L-2 EAD holder with proper licensure satisfies.
Minimum $30,000/month in prescription dispensing and ancillary revenue. Established pharmacies with consistent prescription volume and insurance contracts are strong candidates.
Yes. Specialty pharmacies — oncology, HIV, transplant, fertility, and rare disease — typically have much higher revenue per prescription and serve patients not well-served by chain pharmacies. Specialty pharmacy is a premium market segment for L-2 EAD pharmacist entrepreneurs.
Yes. Insurance reimbursement (PBM payments) typically arrives 14-30 days after dispensing. Meanwhile, drug costs must be paid quickly. Bankable's working capital bridges this timing gap.
Yes. Compounding pharmacies — both sterile (503A/503B) and non-sterile — are eligible. Compounding revenue, patient-specific compound pricing, and institutional contracts all count as business revenue.
Yes. Acquiring an established pharmacy with existing prescription volume and patient relationships is a strong acquisition that Bankable can fund. Existing revenue history makes the underwriting straightforward.
All pharmacy revenue — prescriptions, OTC, vitamins, personal care — counts in our underwriting. A strong front-end business alongside prescription dispensing is a positive indicator.
340B program pharmacies require specific eligibility (covered entity relationships). We evaluate your total revenue and can discuss 340B-specific structures with you.